Le Journal des biotechs : Nawal Ouzren (Sensorion), Jamila El Bougrini (Invest Securities)

from Le Journal des Biotechs · host BOURSORAMA

Dans ce numéro du Journal des biotechs, Jamila El Bougrini évoque les entreprises qui ont récemment fait l'actualité : Transgene, Medesis, Biocorp et Nanobiotix.L'entretien est consacré à Nawal Ouzren. La directrice générale de Sensrion revient sur derniers développements de son actif le plus avancé SENS 401 et fait le point sur les actifs de la biotech en thérapie génique.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Jun 15, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Le Journal des biotechs : Nawal Ouzren (Sensorion), Jamila El Bougrini (Invest Securities)

0:00 31:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 31 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on June 15, 2023.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!